CGTX · Cognition Therapeutics Inc
$1.01
-0.03 (-2.88%)
At close · Aug 14
Market Cap
$96.04M
Shares
95.09M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-12-18 | — | $75,000,000 | $75,000,000 as of 2026-03-31 | — | 10-Q , filed 2026-05-08 |
Key facts
CIK
1455365
CUSIP
19243B102
13F (30d)
60 filings
60 filers
Visit website
Investor relations